Favourable outcome of pulmonary zygomycosis in haematological malignancy.
Opeskin
Kenneth
K
Sheorey
Harsha
H
Wright
Gavin
G
Nandurkar
Harshal
H
D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D006801:Humans; D016867:Immunocompromised Host; D008081:Liposomes; D008172:Lung Diseases, Fungal / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000276:immunology / Q000473:pathology*; D016896:Treatment Outcome; D020096:Zygomycosis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology
D000935:Antifungal Agents; D008081:Liposomes; C068538:liposomal amphotericin B; D000666:Amphotericin B